Genetics of familial melanoma: 20 years afterCDKN2A
Author:
Affiliation:
1. QIMR Berghofer Medical Research Institute; Brisbane Qld Australia
2. University of Queensland; Brisbane Qld Australia
3. Department of Clinical Genetics; Rigshospitalet; Copenhagen Denmark
Funder
National Health and Medical Research Council of Australia
Cure Cancer Australia
Australia and New Zealand Banking Group Limited Trustees and Rigshospitalet
University Hospital of Copenhagen
Publisher
Wiley
Subject
Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/pcmr.12333/fullpdf
Reference111 articles.
1. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers;Abdel-Rahman;J. Med. Genet.,2011
2. CDKN2A variants in a population-based sample of Queensland families with melanoma;Aitken;J. Natl. Cancer Inst.,1999
3. Prevalence of germline BAP1 mutation in a population-based sample of uveal melanoma cases;Aoude;Pigment Cell Melanoma Res.,2013
4. Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma;Aoude;J. Natl. Cancer Inst.,2014
5. Familial cutaneous malignant melanoma and tumors of the nervous system. A hereditary cancer syndrome;Azizi;Cancer,1995
Cited by 117 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. CDKN2A Gene Mutations: Implications for Hereditary Cancer Syndromes;Biomedicines;2023-12-18
2. Characterization of Potential Melanoma Predisposition Genes in High-Risk Brazilian Patients;International Journal of Molecular Sciences;2023-10-31
3. UV-radiation and MC1R germline mutations are risk factors for the development of conventional and spitzoid melanomas in children and adolescents;eBioMedicine;2023-10
4. A comprehensive review on novel targeted therapy methods and nanotechnology-based gene delivery systems in melanoma;European Journal of Pharmaceutical Sciences;2023-08
5. CDKN2A/CDK4 status in Brazilian patients meeting clinical criteria for hereditary melanoma: a cross‐sectional descriptive trial;International Journal of Dermatology;2023-06-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3